Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 416

1.

Seroprevalence of measles, mumps and rubella among children in American Samoa, 2011, and progress towards West Pacific Region goals of elimination.

Mahamud A, Masunu-Faleafaga Y, Walls L, Williams N, Garcia P, Teshale E, Williams R, Dulski T, Bellini WJ, Kutty PK.

Vaccine. 2013 Aug 12;31(36):3683-7. doi: 10.1016/j.vaccine.2013.05.102. Epub 2013 Jun 13.

PMID:
23770334
2.

Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.

Wang Z, Yan R, He H, Li Q, Chen G, Yang S, Chen E.

PLoS One. 2014 Feb 20;9(2):e89361. doi: 10.1371/journal.pone.0089361. eCollection 2014.

3.

Seroprevalence of measles, mumps and rubella among young adults, after 20 years of universal 2-dose MMR vaccination in Israel.

Levine H, Zarka S, Ankol OE, Rozhavski V, Davidovitch N, Aboudy Y, Balicer RD.

Hum Vaccin Immunother. 2015;11(6):1400-5. doi: 10.1080/21645515.2015.1032489.

4.

[Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].

Stohrer-Draxl P, Amstad H, Grize L, Gassner M, Takken-Sahli K, Bourquin C, Braun-Fahrländer C.

Praxis (Bern 1994). 1999 Jun 10;88(24):1069-77. German.

PMID:
10420798
5.

Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).

McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS; Centers for Disease Control and Prevention..

MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34. Erratum in: MMWR Recomm Rep. 2015 Mar 13;64(9):259.

6.

Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India.

Gohil DJ, Kothari ST, Chaudhari AB, Gunale BK, Kulkarni PS, Deshmukh RA, Chowdhary AS.

Viral Immunol. 2016 Apr;29(3):159-63. doi: 10.1089/vim.2015.0070. Epub 2016 Feb 24.

PMID:
26910764
7.
8.

High seroprevalence of varicella, measles, mumps, rubella and pertussis antibodies in first-grade medical students.

Socan M, Berginc N.

Wien Klin Wochenschr. 2008;120(13-14):422-6. doi: 10.1007/s00508-008-1005-6.

PMID:
18726668
9.

MMR vaccination, measles epidemiology and sero-surveillance in the Republic of Ireland.

Johnson H, Hillary IB, McQuoid G, Gilmer BA.

Vaccine. 1995 Apr;13(6):533-7.

PMID:
7483773
10.
11.

Seroprevalence of antibodies to measles, mumps, and rubella among Thai population: evaluation of measles/MMR immunization programme.

Tharmaphornpilas P, Yoocharean P, Rasdjarmrearnsook AO, Theamboonlers A, Poovorawan Y.

J Health Popul Nutr. 2009 Feb;27(1):80-6.

12.

Prevalence of antibodies against measles, mumps, and rubella before and after vaccination of school-age children with three different triple combined viral vaccines, Rio Grande do Sul, Brazil, 1996.

dos Santos BA, Stralioto SM, Siqueira MM, Ranieri TS, Bercini M, Schermann MT, Wagner MB, Silveira TR.

Rev Panam Salud Publica. 2006 Nov;20(5):299-306.

PMID:
17316487
13.
15.

Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children.

Rafiei Tabatabaei S, Esteghamati AR, Shiva F, Fallah F, Radmanesh R, Abdinia B, Shamshiri AR, Khairkhah M, Shekari Ebrahimabad H, Karimi A.

Arch Iran Med. 2013 Jan;16(1):38-41. doi: 013161/AIM.0012.

16.

Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity.

Poethko-Müller C, Mankertz A.

PLoS One. 2012;7(8):e42867. doi: 10.1371/journal.pone.0042867. Epub 2012 Aug 6.

17.

[Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].

Zäch K, Nicoara C, Germann D, Matter L.

Schweiz Med Wochenschr. 1998 Apr 25;128(17):649-57. German.

PMID:
9622837
18.

[Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid].

Gil Miguel A, Astasio Arbiza P, Ortega Molina P, Domínguez Rojas V, González López A.

An Esp Pediatr. 1999 May;50(5):459-62. Spanish.

PMID:
10394183
19.

Progress towards measles and rubella elimination in Tuscany, Italy: the role of population seroepidemiological profile.

Bechini A, Boccalini S, Tiscione E, Pesavento G, Mannelli F, Peruzzi M, Rapi S, Mercurio S, Bonanni P.

Eur J Public Health. 2012 Feb;22(1):133-9. doi: 10.1093/eurpub/ckq134. Epub 2010 Sep 29.

PMID:
20880991
20.

Prevalence of anti-rubella, anti-measles and anti-mumps IgG antibodies in neonates and pregnant women in Catalonia (Spain) in 2013: susceptibility to measles increased from 2003 to 2013.

Plans P, de Ory F, Campins M, Álvarez E, Payà T, Guisasola E, Compte C, Vellbé K, Sánchez C, Lozano MJ, Aran I, Bonmatí A, Carreras R, Jané M, Cabero L.

Eur J Clin Microbiol Infect Dis. 2015 Jun;34(6):1161-71. doi: 10.1007/s10096-015-2339-4. Epub 2015 Feb 10.

PMID:
25666082

Supplemental Content

Support Center